204 related articles for article (PubMed ID: 2140991)
21. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro.
Hodges LC; Bergerson JS; Hunter DS; Walker CL
Toxicol Sci; 2000 Apr; 54(2):355-64. PubMed ID: 10774817
[TBL] [Abstract][Full Text] [Related]
22. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
van Leusden HA; Dogterom AA
Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
[TBL] [Abstract][Full Text] [Related]
23. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
Pasqualini JR; Gelly C; Nguyen BL
Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
[TBL] [Abstract][Full Text] [Related]
24. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.
Chrapusta S; Konopka B; Paszko Z; Sieinski W; Szamborski J
Eur J Gynaecol Oncol; 1990; 11(4):275-81. PubMed ID: 2245811
[TBL] [Abstract][Full Text] [Related]
26. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
27. Gonadotropin-releasing hormone effects on placental hormones during gestation: II. Progesterone, estrone, estradiol and estriol.
Siler-Khodr TM; Khodr GS; Valenzuela G; Rhode J
Biol Reprod; 1986 Mar; 34(2):255-64. PubMed ID: 3513854
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
[No Abstract] [Full Text] [Related]
29. Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment.
Monsonego J; Destable MD; De Saint Florent G; Amouroux J; Kouyoundjian JC; Haour F; Breau JL; Israel L; Comaru-Schally AM; Schally AV
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1181-9. PubMed ID: 1852100
[TBL] [Abstract][Full Text] [Related]
30. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
[TBL] [Abstract][Full Text] [Related]
32. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
van Leusden HA
Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
[No Abstract] [Full Text] [Related]
33. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
Severino MF; Murray MJ; Brandon DD; Clinton GM; Burry KA; Novy MJ
Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
36. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Wiznitzer A; Marbach M; Hazum E; Insler V; Sharoni Y; Levy J
Biochem Biophys Res Commun; 1988 May; 152(3):1326-31. PubMed ID: 2837183
[TBL] [Abstract][Full Text] [Related]
37. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Lumsden MA; West CP; Hawkins RA; Bramley TA; Rumgay L; Baird DT
J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
[TBL] [Abstract][Full Text] [Related]
38. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
39. Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue.
Pollow K; Geilfuss J; Boquoi E; Pollow B
J Clin Chem Clin Biochem; 1978 Sep; 16(9):503-11. PubMed ID: 712341
[TBL] [Abstract][Full Text] [Related]
40. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
Cheng YM; Chou CY; Huang SC; Lin HC
BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
